[go: up one dir, main page]

NO180796C - Fremgangsmåte for fremstilling av et glykoprotein, TCF-II, samt cDNA som koder for proteinet - Google Patents

Fremgangsmåte for fremstilling av et glykoprotein, TCF-II, samt cDNA som koder for proteinet

Info

Publication number
NO180796C
NO180796C NO913546A NO913546A NO180796C NO 180796 C NO180796 C NO 180796C NO 913546 A NO913546 A NO 913546A NO 913546 A NO913546 A NO 913546A NO 180796 C NO180796 C NO 180796C
Authority
NO
Norway
Prior art keywords
glycoprotein
tcf
protein
preparation
well
Prior art date
Application number
NO913546A
Other languages
English (en)
Other versions
NO913546L (no
NO180796B (no
NO913546D0 (no
Inventor
Kanji Higashio
Shinjiro Mitsuda
Nobuyuki Shima
Yasuharu Itagaki
Masaya Nagao
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26340889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO180796(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of NO913546D0 publication Critical patent/NO913546D0/no
Publication of NO913546L publication Critical patent/NO913546L/no
Publication of NO180796B publication Critical patent/NO180796B/no
Publication of NO180796C publication Critical patent/NO180796C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO913546A 1989-03-10 1991-09-09 Fremgangsmåte for fremstilling av et glykoprotein, TCF-II, samt cDNA som koder for proteinet NO180796C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP5863189 1989-03-10
JP669290 1990-01-16
PCT/JP1990/000314 WO1990010651A1 (fr) 1989-03-10 1990-03-09 Glycoproteine humaine, facteur physiologiquement actif la contenant, et preparation pharmaceutique le contenant en tant qu'ingredient actif

Publications (4)

Publication Number Publication Date
NO913546D0 NO913546D0 (no) 1991-09-09
NO913546L NO913546L (no) 1991-11-11
NO180796B NO180796B (no) 1997-03-17
NO180796C true NO180796C (no) 1997-06-25

Family

ID=26340889

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913546A NO180796C (no) 1989-03-10 1991-09-09 Fremgangsmåte for fremstilling av et glykoprotein, TCF-II, samt cDNA som koder for proteinet

Country Status (17)

Country Link
US (2) US5587359A (no)
EP (1) EP0462277B1 (no)
JP (1) JPH0768272B1 (no)
KR (1) KR960009054B1 (no)
AT (1) ATE123498T1 (no)
AU (1) AU629314B2 (no)
CA (1) CA2049017C (no)
DE (1) DE69019962T2 (no)
DK (1) DK0462277T3 (no)
ES (1) ES2075199T3 (no)
FI (1) FI102681B (no)
HU (2) HU212513B (no)
IE (1) IE64005B1 (no)
NO (1) NO180796C (no)
NZ (1) NZ232813A (no)
RU (1) RU2113480C1 (no)
WO (1) WO1990010651A1 (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362716A (en) * 1989-12-27 1994-11-08 The United States Of America As Represented By The Department Of Health And Human Services Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
EP0859009B1 (en) * 1990-06-11 2005-11-30 Toshikazu Nakamura Recombinant human hepatocyte growth factor and method for production thereof
ATE178354T1 (de) * 1990-07-13 1999-04-15 Snow Brand Milk Products Co Ltd Plasmid das für die aminosäuresequenz von tcf-ii kodierende dns enthalt, transformierte zelle und produktion einer physiologisch aktiven substanz mit ihrer verwendung
EP0571387B1 (en) * 1990-09-14 2003-12-17 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce A non-mitogenic competitive hgf antagonist
US5821223A (en) * 1990-09-14 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen
JP3200609B2 (ja) * 1990-12-28 2001-08-20 敏一 中村 上皮細胞増殖促進剤
JPH0597A (ja) * 1991-06-21 1993-01-08 Snow Brand Milk Prod Co Ltd 新規抗ｔｃｆ−ｉｉモノクローナル抗体及びそれを用いるｔｃｆ−ｉｉの測定方法
CA2100720C (en) 1992-07-16 2003-03-11 Hiroaki Masunaga Medicinal composition comprising tcf-ii
DK0653211T3 (da) * 1992-07-16 2002-05-06 Daiichi Seiyaku Co Blodkoagulationsnormalisator indeholdende TCF-II som aktiv bestanddel
CA2130561A1 (en) * 1992-12-28 1994-07-07 Kyoji Yamaguchi Modified tcf
JP3552240B2 (ja) * 1993-02-23 2004-08-11 第一製薬株式会社 高濃度ｔｃｆ製剤
US5837676A (en) * 1993-10-18 1998-11-17 Long Island Jewish Medical Center Use of scatter factor to enhance angiogenesis
JP2747979B2 (ja) * 1994-08-19 1998-05-06 雪印乳業株式会社 ヒト由来の糖蛋白質からなる生理活性因子を有効成分とする医薬
JPH08176007A (ja) * 1994-12-27 1996-07-09 Snow Brand Milk Prod Co Ltd 脂質代謝異常治療剤
WO1996020214A1 (en) * 1994-12-27 1996-07-04 Snow Brand Milk Products Co., Ltd. Tcf mutant
AU4027601A (en) * 1995-07-11 2001-07-26 Snow Brand Milk Products Co., Ltd. Lyophilized HGF preparations
JP3927248B2 (ja) * 1995-07-11 2007-06-06 第一製薬株式会社 Ｈｇｆ凍結乾燥製剤
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
EP0950416B1 (en) * 1997-03-14 2006-11-02 Daiichi Pharmaceutical Co., Ltd. Use of TCF-II for the treatment of cancer related body weight loss, anaemia and TNF elevation
JPH1129493A (ja) * 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び／又は治療剤
JPH11269091A (ja) * 1998-03-19 1999-10-05 Snow Brand Milk Prod Co Ltd 敗血症予防及び／又は治療剤
CN1352087A (zh) * 2000-11-02 2002-06-05 上海博德基因开发有限公司 一种新的多肽——人糖蛋白42和编码这种多肽的多核苷酸
KR100562824B1 (ko) * 2002-03-20 2006-03-23 주식회사 바이로메드 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
CN100417412C (zh) * 2003-03-28 2008-09-10 威海赛洛金药业有限公司 促肝细胞生长素注射液及制备方法和应用
JP4728807B2 (ja) * 2003-09-03 2011-07-20 敏一 中村 ヒト組換えｈｇｆを含有する皮膚潰瘍予防治癒剤
CA2640010A1 (en) * 2006-01-25 2007-08-02 Octapharma Ag Purification and use of a factor for supporting wound healing
WO2008136183A1 (ja) * 2007-04-28 2008-11-13 Applied Cell Biotechnologies, Inc. 皮膚または歯肉の軟組織の欠損を補修するための組成物，及び自己線維芽細胞の培養方法
US20090202606A1 (en) * 2008-01-25 2009-08-13 Viromed Co., Ltd. Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor
ES2556711T3 (es) * 2008-04-09 2016-01-19 Viromed Co., Ltd. Formulaciones liofilizadas de ADN para el aumento de la expresión del ADN plasmídico
MX375916B (es) 2013-10-22 2025-03-07 Helixmith Co Ltd Composicion para prevenir o tratar la esclerosis lateral amiotrofica usando dos o mas isoformas del factor de crecimiento de hepatocito.
WO2015166885A1 (ja) * 2014-04-28 2015-11-05 エーザイ・アール・アンド・ディー・マネジメント株式会社 Ｈｇｆ凍結乾燥製剤
JP6281992B2 (ja) 2014-09-10 2018-02-21 クリングルファーマ株式会社 神経疾患の治療に適したｈｇｆ製剤
JP6861201B2 (ja) 2016-03-17 2021-04-21 エーザイ・アール・アンド・ディー・マネジメント株式会社 活性型肝細胞増殖因子（ｈｇｆ）の製造方法
JP7212230B2 (ja) 2018-07-19 2023-01-25 ヘリックスミス カンパニー， リミテッド ネイキッドｄｎａ遺伝子療法のための凍結乾燥した薬剤学的組成物
AU2022272740A1 (en) 2021-05-14 2023-11-02 Claris Biotherapeutics, Inc. Compositions of growth factor for the treatment of eye disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58148826A (ja) * 1982-02-26 1983-09-05 Mochida Pharmaceut Co Ltd 糖蛋白質および腫瘍治療剤
JP2564486B2 (ja) * 1986-07-14 1996-12-18 修治 橋本 肝細胞増殖因子
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
DE3643182A1 (de) * 1986-12-18 1988-06-30 Behringwerke Ag Arzneimittel enthaltend das gewebeprotein pp4, verfahren zur herstellung von pp4 und zu seiner pasteurisierung sowie die verwendung von pp4
JPS6410998A (en) * 1986-12-22 1989-01-13 Green Cross Corp Tumor cell inhibitory factor
JPS63243032A (ja) * 1987-03-27 1988-10-07 Green Cross Corp:The トロンビンの加熱処理方法
DE3729863A1 (de) * 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate
JPH0741891B2 (ja) * 1987-08-26 1995-05-10 凸版印刷株式会社 容器素材成形装置
FI80741C (fi) * 1987-10-29 1990-07-10 Laennen Tehtaat Oy Modifierat papper.
ATE178354T1 (de) * 1990-07-13 1999-04-15 Snow Brand Milk Products Co Ltd Plasmid das für die aminosäuresequenz von tcf-ii kodierende dns enthalt, transformierte zelle und produktion einer physiologisch aktiven substanz mit ihrer verwendung

Also Published As

Publication number Publication date
FI102681B1 (fi) 1999-01-29
EP0462277A1 (en) 1991-12-27
WO1990010651A1 (fr) 1990-09-20
KR960009054B1 (ko) 1996-07-10
DE69019962T2 (de) 1995-11-23
EP0462277A4 (en) 1992-08-12
AU5177490A (en) 1990-10-09
ES2075199T3 (es) 1995-10-01
DE69019962D1 (de) 1995-07-13
HU211229A9 (en) 1995-11-28
NZ232813A (en) 1992-08-26
DK0462277T3 (da) 1995-10-30
IE64005B1 (en) 1995-06-28
NO913546L (no) 1991-11-11
US6333309B1 (en) 2001-12-25
HU212513B (en) 1996-07-29
EP0462277B1 (en) 1995-06-07
RU2113480C1 (ru) 1998-06-20
JPH0768272B1 (no) 1995-07-26
FI914234A0 (fi) 1991-09-09
KR920701256A (ko) 1992-08-11
ATE123498T1 (de) 1995-06-15
HU902330D0 (en) 1991-12-30
NO180796B (no) 1997-03-17
CA2049017C (en) 1998-10-27
IE900863L (en) 1990-09-10
FI102681B (fi) 1999-01-29
NO913546D0 (no) 1991-09-09
RU95110767A (ru) 1997-06-10
US5587359A (en) 1996-12-24
CA2049017A1 (en) 1990-09-11
HUT58797A (en) 1992-03-30
AU629314B2 (en) 1992-10-01

Similar Documents

Publication Publication Date Title
NO180796C (no) Fremgangsmåte for fremstilling av et glykoprotein, TCF-II, samt cDNA som koder for proteinet
ES8500325A1 (es) Procedimiento para la preparacion de proteinas funcionales de uroquinasa humana.
GR3035627T3 (en) A mammalian cytokine, il-11.
DE3586697D1 (en) Aktive thymopentin-analoga.
CS40289A3 (en) Method of vital viral cultures maintenance
EP0379556A4 (en) Production of glucose oxidase in recombinant systems
HK1015611A1 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
AU2525284A (en) Human nerve growth factor by recombinant technology
EP0212474A3 (en) Bone morphogenetic peptides
IT8621106A0 (it) Vettore ad espressione e secrezione in lieviti, utile per lapreparazione di proteine eterologhe.
DE3788796D1 (de) Serumfreies medium zur proliferation von lymphokin-aktivierten töterzellen.
DE59010897D1 (de) Expressionsvektoren zur Synthese von Proteinen in der Spalthefe Schizosaccharomyces pombe
DE69011295D1 (de) Landungshilfssystem vom Typ MLS mit zentralen Mitteln zur Erzeugung von Mikrowellen.
DE3684474D1 (de) Verwendung von cobalt proto-und mesoporphyrin zur herstellungeines arzneimittels zur hemmung des endocrinen systems.
DE69011296D1 (de) Landungshilfssystem vom Typ MLS, mit zentralen Mitteln zur Erzeugung von Mikrowellen.
IT8620411A0 (it) Procedimento per la produzione difosfati misti di zirconio e titanio e prodotti ottenuti.
IT8741622A0 (it) Procedimento per la realizzazione di arazzi componibili e mezzi per attuare il detto procedimento.

Legal Events

Date Code Title Description
MK1K Patent expired